[1]李莎,焦战,陈青,等.瞬时弹性成像技术评价自拟中药治疗肝纤维化的临床疗效[J].西部中医药,2020,33(08):89-92.[doi:10.12174/j.issn.1004-6852.2020.08.23]
 LI Sha,JIAO Zhan,CHEN Qing,et al.Clinical Effects of Selfmade Herbs in Treating Liver Fibrosis Evaluated by Transient Elastography[J].Western Journal of Traditional Chinese Medicine,2020,33(08):89-92.[doi:10.12174/j.issn.1004-6852.2020.08.23]
点击复制

瞬时弹性成像技术评价自拟中药治疗肝纤维化的临床疗效
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年08期
页码:
89-92
栏目:
出版日期:
2020-08-15

文章信息/Info

Title:
Clinical Effects of Selfmade Herbs in Treating Liver Fibrosis Evaluated by Transient Elastography
文章编号:
1004-6852(2020)08-0089-04
作者:
李莎1焦战2陈青3王思源4刘楠5郭鸿6
1 辽宁省健康产业集团铁煤总医院,辽宁 调兵山 112700; 2 中国人民解放军联勤保障部队第九六七医院; 3 大连阜康门诊; 4 大连医科大学第一临床学院; 5 辽宁省人民医院; 6 内蒙古医科大学附属人民医院;
Author(s):
LI Sha1, JIAO Zhan2, CHEN Qing3, WANG Siyuan4, LIU Nan5, GUO Hong6
1 General Hospital of Tiefa Coal Industry Group of Liaoning Health Industry Group, Diaobingshan 112700, China;2 967 Hospital of the Joint logistics support force of PLA; 3 Dalian Fukang Clinic;4 First Clinical Medical School, Dalian Medical Universit
关键词:
肝纤维化自拟中药肝脏硬度值瞬时弹性成像
Keywords:
liver fibrosis selfmade herbs LSM TE
分类号:
R445.1
DOI:
10.12174/j.issn.1004-6852.2020.08.23
文献标志码:
B
摘要:
目的:通过瞬时弹性成像技术(transient elastography,TE)评价自拟中药治疗6个月对肝纤维化的改善程度。方法:筛选肝纤维化患者80例,随机分为对照组和观察组,每组40例,对照组予以扶正化瘀胶囊治疗6个月,观察组予以自拟中药治疗6个月。所有患者在治疗前后均进行TE检查并记录肝脏硬度值(liver stiffness measurement,LSM),检查血清α2巨球蛋白(α2-macroglobulin,α2-MG)、结合珠蛋白(haptoglobin,HAP)、谷氨酰转肽酶(glutamyltranspetidase,GGT)、总胆红素(total bilirubin,TBII)、载脂蛋白Al(apolipoprotein,ApoAl)并计算FibroTest值(FT)。对比两组患者治疗前后的LSM值及FT值,并对其进行相关性分析,对肝纤维化的改善程度进行评价。结果:α2-MG、HAP、ApoAl、TBII、GGT治疗前后两组组内比较,差异均有统计学意义(P<0.05);ApoAl、TBIL治疗后两组组间比较,差异有统计学意义(P<0.05)。两组治疗前后FT值与LSM值治疗前后两组组内比较,差异有统计学意义(P<0.05);治疗后两组组间比较差异也有统计学意义(P<0.05)。治疗前后两组的FT值与LSM值差异有统计学意义(P<0.05)。结论:TE技术可以应用于肝脏硬度的测量,有利于诊断和评估肝纤维化的程度及分期。自拟中药可降低肝脏LSM值,对于治疗肝纤维化具有较好的疗效,能够阻止及逆转肝脏的纤维化程度。
Abstract:
Objective: To assess the improvement degrees of liver fibrosis treated by selfmade herbs via transient elastography (TE). Methods: Eighty patients were screened, randomized into the control group and the observation group, 40 cases each group, the control group took Fuzheng Huayu capsules for six months, and the observation group were given selfmade herbs for six months. All the patients performed TE examinations before and after treating to record LSM, detect α2-MG, HAP, GGT, TBIL, ApoAI, and calculate FT. To compare LSM and FT before and after treating between both groups, and relevance analysis was performed to assess the improvements of liver fibrosis. Results: The difference had statistical meaning in α2-MG, HAP, ApoAI, TBIL and GGT before and after treating within two groups (P<0.05); the difference showed statistical meaning in ApoAI and TBIL between both groups after treating (P<0.05). The difference had statistical meaning in FT and LSM before and after treating within two groups (P<0.05); the difference was statistically significant between both groups after treating (P<0.05). FT was significantly correlated with LSM before and after treating in both groups (P<0.05). Conclusion: TE technology could be applied to measure liver stiffness, and it could help diagnose and assess the degrees and phasing of liver fibrosis. Selfmade herbs could lower LSM of liver, showing better effects for liver fibrosis, it could block and reverse the degree of fibrosis.

相似文献/References:

[1]于立友,汪龙德△,张晶,等.化纤保肝方治疗气滞血瘀型肝纤维化的临床研究*[J].西部中医药,2013,26(10):84.
 YU Liyou,WANG Longde,ZHANG Jing,et al.Clinical Study on HuaQian BaoGan Prescription in the Treatment for Hepatic Fibrosis of Qi Staganation and Blood Stasis Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(08):84.
[2]刘成,杨宗国,陆云飞,等.消黄方对大鼠胆汁淤积性肝纤维化的干预作用*[J].西部中医药,2012,25(11):14.
 LIU Cheng,YANG Zong-guo,LU Yun-fei,et al.Therapeutic Effects of XiaoHuangFang on Cholestatic Liver Fibrosis in Rats[J].Western Journal of Traditional Chinese Medicine,2012,25(08):14.
[3]郭守强.苦参碱对肝纤维化大鼠转化生长因子β1表达的影响[J].西部中医药,2014,27(06):13.
 GUO Shouqiang.The Effects of Matrine on the Expressions of TGF-β1 of the Rats with Liver Fibrosis[J].Western Journal of Traditional Chinese Medicine,2014,27(08):13.
[4]闫雪华.恩替卡韦联合复方鳖甲软肝片治疗代偿期乙肝肝硬化疗效观察[J].西部中医药,2014,27(07):84.
 YAN Xuehua.Clinical Observation on Entecavir Combined with Compound BieJia RuanGan Tablets in Treating Decompensated Liver Cirrhosis of Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2014,27(08):84.
[5]陈耀章,李根旺.冬虫夏草对心肝肾的保护作用研究[J].西部中医药,2016,29(04):127.
 CHEN Yaozhang,LI Genwang.Study on the Protective Effects of DongChong XiaCao to Heart, Liver and Kidney[J].Western Journal of Traditional Chinese Medicine,2016,29(08):127.
[6]张玉玲,闫雪华△,谢青.中药联合抗病毒药物治疗HBV所致肝纤维化的研究进展[J].西部中医药,2019,32(06):149.
 ZHANG Yuling,YAN Xuehua,XIE Qing.The Progress of Herbs Joined with Antiviral Drugs in the Treatment for HBV - induced Hepatic Fibrosis[J].Western Journal of Traditional Chinese Medicine,2019,32(08):149.
[7]段桂姣,王振常,吴珊珊.柔肝化纤颗粒对肝纤维化模型大鼠肝组织超氧化物歧化酶和丙二醛的影响[J].西部中医药,2022,35(04):30.[doi:10.12174/j.issn.2096-9600.2022.04.08]
 DUAN Guijiao,WANG Zhenchang,Wu Shanshan.Effects of Rougan Huaxian Granules on SOD and MDA in Liver Tissue of Rats with Hepatic Fibrosis[J].Western Journal of Traditional Chinese Medicine,2022,35(08):30.[doi:10.12174/j.issn.2096-9600.2022.04.08]
[8]徐俊,戚璐,许杰,等.抗纤软肝颗粒对肝纤维化小鼠肠道黏膜通透性的影响[J].西部中医药,2022,35(07):27.[doi:10.12174/j.issn.2096-9600.2022.07.07]
 XU Jun,QI Lu,XU Jie,et al.Influence of Anti-fibrosis Liver-softening Granules on Intestinal Mucosal Permeability in Hepatic Fibrosis Mice[J].Western Journal of Traditional Chinese Medicine,2022,35(08):27.[doi:10.12174/j.issn.2096-9600.2022.07.07]
[9]陈懿榕,阙任烨,刘进锴,等.柴胡皂苷d对大鼠肝星状细胞TGFβ-Smad信号通路mRNA表达的影响[J].西部中医药,2022,35(08):15.[doi:10.12174/j.issn.2096-9600.2022.08.04]
 CHEN Yirong,QUE Renye,LIU Jinkai,et al.Influence of Saikosaponins-d on the Expressions of TGFβ-Smad Signal Path mRNA in Rat Hepatic Stellate Cells[J].Western Journal of Traditional Chinese Medicine,2022,35(08):15.[doi:10.12174/j.issn.2096-9600.2022.08.04]
[10]郭召平,苏琴,黄天生.化痰助运通络方治疗痰瘀互结型非酒精性脂肪肝肝纤维化临床研究[J].西部中医药,2021,34(05):122.[doi:10.12174/j.issn.2096-9600.2021.05.31]
 GUO Zhaoping,SU Qin,HUANG Tiansheng.Clinical Study on Treating Non Alcoholic Fatty Liver Fibrosis of Phlegm and Blood Stasis Pattern by Resolving-phlegm Promoting-transportation Dredging-collateral Prescription[J].Western Journal of Traditional Chinese Medicine,2021,34(08):122.[doi:10.12174/j.issn.2096-9600.2021.05.31]

备注/Memo

备注/Memo:
收稿日期:2019-09-13作者简介:李莎(1980—),女,硕士学位,副主任医师。研究方向:影像医学与核医学。
更新日期/Last Update: 2020-08-15